Effects of treatment status and life quality on anxiety in MMT patients
Tóm tắt
Anxiety, an important factor that affects the therapeutic effect and preservation rate of methadone maintenance treatment, has a high prevalence among MMT patients. This study aims to investigate the effects of treatment status and life quality on anxiety in MMT patients. One hundred and Seventy-seven methadone maintenance treatment users in Guangzhou, China were evaluated. The socio-demographic, duration and MMT-related characteristics were documented. Anxiety level and quality of life were evaluated by Beck Anxiety inventory (BAI) and the Quality of Life-Drug Addiction (QOL-DA) respectively. The correlation between different factors and BAI score was also analyzed. The BAI total score and the QOL-DA score were 7.1±8.2, 163.5±21.4 respectively. 30.5% of the subjects showed mild to severe anxiety. Treatment interruption and QOL-DA score had strong correlations with the score of BAI, with correlation coefficients of 0.17 and − 0.08 respectively. Anxiety symptoms were commonly presented in MMT patients. Treatment interruption and quality of life are two major factors affecting anxiety of MMT patients.
Tài liệu tham khảo
United Nations. World Drug Report 2019. (2019).
Kreek MJ, LaForge KS, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov. 2002;1:710–26. https://doi.org/10.1038/nrd897.
Shediac-Rizkallah MC, Bone LR. Planning for the sustainability of community-based health programs: conceptual frameworks and future directions for research, practice and policy. Health Educ Res. 1998;13:87–108. https://doi.org/10.1093/her/13.1.87.
Kermode M, Crofts N, Kumar MS, Dorabjee J. Opioid substitution therapy in resource-poor settings. Bull World Health Organ. 2011;89:243. https://doi.org/10.2471/blt.11.086850.
Tran BX, et al. Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam. Harm Reduct J. 2016;13(4). https://doi.org/10.1186/s12954-016-0091-4.
Shi J, et al. The effect of methadone maintenance on illicit opioid use, human immunodeficiency virus and hepatitis C virus infection, health status, employment, and criminal activity among heroin abusers during 6 months of treatment in china. J Addict Med. 2007;1:186–90. https://doi.org/10.1097/ADM.0b013e318156cc19.
National Narcotics Control Commission. Annual Report on Drug Control in China 2019. (2020).
Yin W, et al. Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China. Addiction. 2015;110(Suppl 1):51–60. https://doi.org/10.1111/add.12780.
Callaly T, Trauer T, Munro L, Whelan G. Prevalence of psychiatric disorder in a methadone maintenance population. Aust N Z J Psychiatry. 2001;35:601–5. https://doi.org/10.1080/0004867010060507.
TANG Cai-yun CW, Ying-Hua X, Xia Z, Li L. Study on the impact of community-based methadone maintenance treatment on anxiety and depression of opioid addicts. Chin Prevent Med. 2012;881–884(in Chinese):13.
XU Huili, L. Y., ZHANG Jing, XIE Meiying, CHEN Guolan, LIU Yinhua, XU Wei. Comorbidity Of Psychiatric Disorder In Individuals With Methadone Maintenance Treatment. Chin J Drug Depend 22, 197–199+219. ( in Chinese) (2013).
Anh LT, et al. Multi-level predictors of psychological problems among methadone maintenance treatment patients in difference types of settings in Vietnam. Subst Abuse Treat Prevent Policy. 2019:14.
Jiao M, et al. Resilience associated with mental health problems among methadone maintenance treatment patients in Guangzhou, China. AIDS Care. 2017;29:660–5. https://doi.org/10.1080/09540121.2016.1255705.
Baharudin A, Mislan N, Ibrahim N, Sidi H, Nik Jaafar NR. Depression in male patients on methadone maintenance therapy. Asia Pac Psychiatry. 2013;5(Suppl 1):67–73. https://doi.org/10.1111/appy.12069.
Wolff K. Characterization of methadone overdose: clinical considerations and the scientific evidence. Ther Drug Monit. 2002;24:457–70. https://doi.org/10.1097/00007691-200208000-00001.
Greenwald MK. Heroin craving and drug use in opioid-maintained volunteers: effects of methadone dose variations. Exp Clin Psychopharmacol. 2002;10:39–46. https://doi.org/10.1037//1064-1297.10.1.39.
Xu YM, Zhong BL, Chen WC, Zhu JH, Lu J. Suicidal ideation among Chinese methadone-maintained patients: prevalence and correlates. Oncotarget, 8. 2017:86181–7. https://doi.org/10.18632/oncotarget.21032.
Richard S, Kim W, Jane ME, John S. Persistence of heroin use despite methadone treatment: poor coping self-efficacy predicts continued heroin use. Drug Alcohol Rev. 2009;28.
Bruna B, et al. The impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis. 2008:27.
Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S467–72. https://doi.org/10.1002/acr.20561.
Beck AT, N E, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988:56.
Wan C, et al. Development and validation of a quality of life instrument for patients with drug dependence: comparisons with SF-36 and WHOQOL-100. Int J Nurs Stud, 48. 2011:1080–95. https://doi.org/10.1016/j.ijnurstu.2011.02.012.
Zhu D, et al. Beneficial effects of Tai Chi for amphetamine-type stimulant dependence: a pilot study. Am J Drug Alcohol Abuse, 42. 2016:469, 478. https://doi.org/10.3109/00952990.2016.1153646.
Veilleux JC, Colvin PJ, Anderson J, York C, Heinz AJ. A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev. 2010;30:155–66. https://doi.org/10.1016/j.cpr.2009.10.006.
Soyka M, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence. World J Biol Psychiatry. 2011;12:160–87. https://doi.org/10.3109/15622975.2011.561872.
Lin C, Detels R. A qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China. Drug Alcohol Depend. 2011;117:45–9. https://doi.org/10.1016/j.drugalcdep.2011.01.004.
Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K. Methadone maintenance dosing guideline for opioid dependence, a literature review. J Addict Dis. 2010;29:1–14. https://doi.org/10.1080/10550880903436010.
Iskandar S, et al. Severity of psychiatric and physical problems is associated with lower quality of life in methadone patients in Indonesia. Am J Addict. 2013;22:425–31. https://doi.org/10.1111/j.1521-0391.2013.00334.x.
Carpentier PJ, et al. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict. 2009;18:470–80. https://doi.org/10.3109/10550490903205652.
G FH, P BS, Cindy M, H SS. The relationship between self-reported substance use and psychiatric symptoms in low-threshold methadone maintenance treatment clients. Harm Reduct J, 8. 2011.
Yen CN, Wang CS, Wang TY, Chen HF, Chang HC. Quality of life and its correlates among heroin users in Taiwan. Kaohsiung J Med Sci. 2011;27:177–83. https://doi.org/10.1016/j.kjms.2010.09.003.
Zhang X, et al. Depression, suicidal ideation, and related factors of methadone maintenance treatment users in Guangzhou, China. AIDS Care, 28. 2016:851–6. https://doi.org/10.1080/09540121.2015.1124981.
Xiang YT, Yu X, Sartorius N, Ungvari GS, Chiu HF. Mental health in China: challenges and progress. Lancet. 2012;380:1715–6. https://doi.org/10.1016/s0140-6736(11)60893-3.
Barry DT, et al. Group-based strategies for stress reduction in methadone maintenance treatment: what do patients want? J Addict Med. 2011;5:181–7. https://doi.org/10.1097/ADM.0b013e3181ee77cl.